Wall Street Analysts Are Bullish on Top Healthcare Picks
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Eli Lilly & Co (LLY – Research Report) and Cigna (CI – Research Report) with bullish sentiments.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Eli Lilly & Co (LLY)
BMO Capital analyst Evan Seigerman maintained a Buy rating on Eli Lilly & Co yesterday. The company’s shares closed last Monday at $1058.56.
According to TipRanks.com, Seigerman is a 5-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Eli Lilly & Co with a $1261.65 average price target, implying a 20.5% upside from current levels. In a report issued on February 19, Barclays also initiated coverage with a Buy rating on the stock with a $1350.00 price target.
See Insiders’ Hot Stocks on TipRanks >>
Cigna (CI)
Deutsche Bank analyst George Hill maintained a Buy rating on Cigna on February 20. The company’s shares closed last Monday at $283.18.
According to TipRanks.com, Hill is a 4-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Cigna with a $334.30 average price target, a 19.8% upside from current levels. In a report issued on February 5, Barclays also maintained a Buy rating on the stock with a $303.00 price target.
